JohnBlamounMDFCCP
Pulmonology • Midland, MICritical Care Medicine, Interventional Pulmonology, Sleep Medicine
Professor of Medicine Clinical Assistant Dean Central Michigan University Midland campus
Dr. Blamoun is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4201 Campus Ridge Drive
Midland, MI 48640Phone+1 989-488-5450Fax+1 989-488-5455
Summary
- Dr. John Blamoun is a pulmonologist in Midland, MI and is affiliated with multiple hospitals in the area, including McLaren Flint, Aleda E. Lutz Veterans Affairs Medical Center, MidMichigan Medical Center-Clare, MidMichigan Medical Center-Gladwin, and MidMichigan Medical Center-Midland. He received his medical degree from Cairo University School of Medicine and has been in practice 19 years. He specializes in critical care medicine, interventional pulmonology, and pleural disease.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Pulmonary Disease and Critical Care Medicine, 2008 - 2009
Seton Hall University-Hackensack Meridian School of MedicineFellowship, Pulmonary Disease, 2006 - 2008
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2003 - 2006
Cairo University School of MedicineClass of 1998
Certifications & Licensure
FL State Medical License 2024 - Present
IL State Medical License 2020 - 2026
IA State Medical License 2012 - 2025
MI State Medical License 2009 - 2025
NJ State Medical License 2006 - 2009- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
- American Board of Internal Medicine Sleep Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Clinical Trials
- Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia Start of enrollment: 2022 Apr 06
- Add-on Reparixin in Adult Patients With ARDS Start of enrollment: 2023 Feb 07
Publications & Presentations
PubMed
- 29 citationsAbatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.Jane A O'Halloran, Emily R Ko, Kevin J Anstrom, Eyal Kedar, Matthew W McCarthy
JAMA. 2023-07-25 - 10 citationsPerspectives on Transitioning Step 1 of the United States Medical Licensing Examination to a Pass/Fail Scoring Model: Defining New Frameworks for Medical Students Appl...John Blamoun, Ahmad Hakemi, Teresa Armstead
Advances in Medical Education and Practice. 2021-02-11 - 1 citationsAbatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial.Stephen J Balevic, Daniel K Benjamin Jr, William G Powderly, P Brian Smith, Daniel Gonzalez
JAMA Network Open. 2024-04-01
Press Mentions
Frontline Healthcare Workers See the Toll of Pandemics on Unvaccinated PatientsOctober 1st, 2021- COVID-19 Hospitalizations Rising, Causing Concern for Doctors in MichiganApril 15th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
